1. Home
  2. PAYP vs TWST Comparison

PAYP vs TWST Comparison

Compare PAYP & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PayPay Corporation American Depository Shares

PAYP

PayPay Corporation American Depository Shares

N/A

Current Price

$14.78

Market Cap

9.8B

Sector

Real Estate

ML Signal

N/A

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

N/A

Current Price

$120.36

Market Cap

9.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAYP
TWST
Founded
2018
2013
Country
Japan
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
9.2B
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
PAYP
TWST
Price
$14.78
$120.36
Analyst Decision
Buy
Buy
Analyst Count
13
13
Target Price
$24.06
★ $168.25
AVG Volume (30 Days)
508.2K
★ 2.4M
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 63.89
EPS
★ N/A
N/A
Revenue
N/A
★ $376,572,000.00
Revenue This Year
$24.65
$21.17
Revenue Next Year
$18.06
$20.24
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 20.32
52 Week Low
$12.07
$23.30
52 Week High
$24.89
$219.71

Technical Indicators

Market Signals
Indicator
PAYP
TWST
Relative Strength Index (RSI) 46.84 38.85
Support Level $14.37 $79.90
Resistance Level $16.41 $155.44
Average True Range (ATR) 0.65 15.43
MACD 0.06 -3.39
Stochastic Oscillator 35.48 4.11

Price Performance

Historical Comparison
PAYP
TWST

About PAYP PayPay Corporation American Depository Shares

PayPay is a financial technology company jointly owned by Softbank and LY. It was founded in 2018, following the success of Alipay and WeChat Pay in China, and was the pioneering code payment app in Japan. Over the past seven years, it has amassed more than 70 million users and is the market leader in code payments.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: